Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Zinplava (bezlotoxumab) for the Treatment of Clostridium Difficile Infection

Drug (Brand / Generic)

Zinplava (bezlotoxumab)

Product Description

Anti-toxin

Current Indication

Clostridium difficile infection

Market Sector

Anti-infective

Developer

Merck

Development Status

Approved in the US
Expand

Go Top